Cholera: Individualised risk assessment for travellers

Website intended for a NZ health professional readership

+Practice

In print

Travel medicine

Cholera: Individualised risk assessment for travellers

31 July 2024

By Jenny Visser

Wednesday 31 July 2024, 12:15 AM

Cholera is considered a low-incidence disease in travellers, but the true impact is difficult to assess [Image: Erik Mclean on Unsplash]

This article summarises three papers about cholera, including the global situation, a new vaccine on its way, and guidelines on who should get vaccinated

This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.25 credits for continuing professional development purposes (1, Educate small, BACK panel - grey

Research

References

1. WHO. Multi-country outbreak of cholera. External Situation Report n. 15. 19 June 2024.

2. Levine MM, Chen WH, Kaper JB, et al. PaxVax CVD 103-HgR single-dose live oral cholera vaccine. Expert Rev Vaccines 2017;16(3):197–213.

3. López-Vélez R, Presotto D. Cholera in travellers: improving vaccination guidance in Europe. J Travel Med 2021;28(1):taaa209.

How to Treat

+How to treat

Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality

Wednesday 29 January 2025, 12:45 AM